12/2
12:39 pm
gh
Rating for GH
Low
Report
Rating for GH
12/2
12:39 pm
gh
Rating for GH
Low
Report
Rating for GH
10/30
03:14 pm
gh
Rating for GH
Medium
Report
Rating for GH
10/30
02:16 pm
gh
Rating for GH
Low
Report
Rating for GH
10/30
02:16 pm
gh
Rating for GH
Low
Report
Rating for GH
10/30
12:47 pm
gh
Rating for GH
Low
Report
Rating for GH
10/30
12:16 pm
gh
Rating for GH
Low
Report
Rating for GH
10/30
12:16 pm
gh
Rating for GH
Low
Report
Rating for GH
10/30
10:59 am
gh
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at UBS Group AG.
10/30
10:07 am
gh
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
10/30
09:34 am
gh
Rating for GH
Low
Report
Rating for GH
10/30
08:14 am
gh
Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
10/30
06:31 am
gh
Rating for GH
Medium
Report
Rating for GH
10/7
01:19 pm
gh
Rating for GH
Low
Report
Rating for GH
10/2
09:50 am
gh
Rating for GH
Low
Report
Rating for GH
10/2
09:50 am
gh
Rating for GH
Low
Report
Rating for GH
10/2
08:02 am
gh
Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
9/26
07:39 am
gh
Rating for GH
Low
Report
Rating for GH
9/25
01:03 pm
gh
Rating for GH
Low
Report
Rating for GH
9/25
12:42 pm
gh
Rating for GH
Low
Report
Rating for GH
9/25
12:28 pm
gh
Rating for GH
Low
Report
Rating for GH
9/25
12:28 pm
gh
Rating for GH
Low
Report
Rating for GH
9/25
12:13 pm
gh
Guardant Health (NASDAQ:GH) had its "outperform" rating reaffirmed by analysts at William Blair.
Low
Report
Guardant Health (NASDAQ:GH) had its "outperform" rating reaffirmed by analysts at William Blair.
9/25
12:13 pm
gh
Guardant Health (NASDAQ:GH) had its "outperform" rating reaffirmed by analysts at William Blair.
Low
Report
Guardant Health (NASDAQ:GH) had its "outperform" rating reaffirmed by analysts at William Blair.
9/25
11:46 am
gh
Rating for GH
Low
Report
Rating for GH